shot-button
Home > Buzz > Mumbai Distributors Back Delius Pharmas Direct Approach

Mumbai Distributors Back Delius Pharma's Direct Approach

Updated on: 21 November,2024 05:14 PM IST  |  Mumbai
Buzz | sumit.zarchobe@mid-day.com

The inventory rollouts align with Delius Pharma's commitment to strengthening its offline presence.

Mumbai Distributors Back Delius Pharma's Direct Approach

Representational image took during market survey

Delius Group, parent to Delius Pharmaceuticals Pvt. Ltd, is transforming Mumbai's pharma market with its direct distribution model across India's top 20 cities. dispatched Goods worth Rs 50 crore to Rs 100 crore reports coming for b2c value.


Distributors of Delius Pharma in Mumbai have expressed positive feedback regarding the company's smooth inventory rotation. With the onboarding of new distributors, Delius Pharma has dispatched goods worth Rs 50 crore to Rs 100 crore according to B2C value in the market, as reported by the All-India Pharma Mumbai Distributors Local Association.

The inventory rollouts align with Delius Pharma's commitment to strengthening its offline presence. As the company expands, Mumbai distributors have praised the direct supply chain model, citing its efficiency and reliability.

“Delius Pharma's direct distribution strategy not only ensures timely supply but also allows distributors to focus on promoting products more effectively," a leading distributor in Mumbai shared.

#PharmaInnovation #HealthcareSolutions #DeliusPharma #EthicalGenerics #PharmaGrowthStrategies

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK